1. In Vivo

Deals Shaping The Medical Industry, December 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in November 2015.

Vigilant Biosciences Inc. signed three new multi-year distribution agreements for marketing of its CE-marked oral cancer diagnostic, the OncAlert oral cancer system. Dentamed Ltd. gets rights in Slovakia and the Czech Republic; SIRAM Ltd. will sell the test in Israel; and Diamedica Ltd. will sell it in Estonia, Latvia, and Lithuania. (Nov.)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deal-Making

More from In Vivo